Alprazolam and Salivary hypersecretion - a phase IV clinical study of FDA data

Summary:

Salivary hypersecretion is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Depression.

The phase IV clinical study analyzes which people have Salivary hypersecretion when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Salivary hypersecretion?

Salivary hypersecretion (excess saliva secretion) is found to be associated with 783 drugs and 1,337 conditions by eHealthMe. Check the latest studies of Salivary hypersecretion.

On Aug, 11, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 99 people (0.07%) have Salivary hypersecretion.

Could Alprazolam cause Salivary hypersecretion?

Among these 99 people:

How long have people been on Alprazolam when they have Salivary hypersecretion? *

What is the gender of people who have Salivary hypersecretion when taking Alprazolam? *

female: 57.73 %
male: 42.27 %

What is the age of people who have Salivary hypersecretion when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

What are other side effects people have besides Salivary hypersecretion? *

Swallowing Difficulty: 21 people, 21.21%
Tremor (trembling or shaking movements in one or more parts of your body): 21 people, 21.21%
Constipation: 19 people, 19.19%
Hyperhidrosis (abnormally increased sweating): 17 people, 17.17%
Nausea (feeling of having an urge to vomit): 17 people, 17.17%
Fatigue (feeling of tiredness): 15 people, 15.15%
Speech Impairment (Adult) (inability to speak (adult)): 15 people, 15.15%
Insomnia (sleeplessness): 14 people, 14.14%
Dizziness: 12 people, 12.12%
Dyspnea (difficult or laboured breathing): 12 people, 12.12%

What are the existing conditions these people have? *

Depression: 18 people, 18.18%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 8 people, 8.08%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 8.08%
High Blood Pressure: 5 people, 5.05%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 4 people, 4.04%
Psychotic Disorder: 4 people, 4.04%
Suicidal Ideation: 3 people, 3.03%
Muscle Spasms (muscle contraction): 3 people, 3.03%
Nervousness: 3 people, 3.03%
Quit Smoking: 3 people, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Salivary hypersecretion?

- Check whether Salivary hypersecretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Salivary hypersecretion:

Salivary hypersecretion (783 drugs)

Browse all the conditions that are associated with Salivary hypersecretion:

Salivary hypersecretion (1,337 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.